Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a ...

Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

Drug development is an unforgiving business. Discovering a novel molecule is difficult enough, but then it can take years of preclinical studies and molecular tweaking to mitigate a drug’s toxicity, ...

Cambridge, MA – Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks ...

Developing effective cardiovascular therapies requires robust, translational preclinical data that can reliably predict ...

Eli Lilly signs a landmark $2.75 billion deal with Insilico Medicine to harness AI for next-generation drug discovery, gaining exclusive rights to preclinical oral therapies and access to a powerful ...

Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug molecules ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

Bringing groundbreaking new drugs to market is no small feat. The journey begins with navigating a complex landscape of research and intellectual property to discover a viable and patentable candidate ...